Skip to content

Optimising evidence-based perioperative nutrition care in patients undergoing reconstruction surgery for head and neck cancer (HNC)

To assess the feasibility of implementing of a digital, patient-led malnutrition screening tool for patients undergoing reconstruction surgeries for head and neck cancer (HNC)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626001044314
Enrollment
5
Registered
2026-08-25
Start date
2026-07-23
Completion date
Unknown
Last updated
2026-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Brief description of the study purpose: This study aims to assess the feasibility of implementing a digital, patient-led malnutrition screening tool for people undergoing jaw reconstruction surgery for head and neck cancer at Chris O'Brien Lifehouse. The study will also involve co-designing the tool with consumers, healthcare professionals, and information technology specialists. Who is it for? You may be eligible for the co-design phase of this study if you are a consumer advisory panel members with experience of head and neck cancer. You may be eligible for the implementation phase of this study if you are aged 18 years or older who are undergoing jaw reconstruction surgery for head and neck cancer at Chris O'Brien Lifehouse, are English-speaking, and have access to a mobile device and the internet. Study details: The study will be conducted in two phases. In Phase 1, consumer advisory panel members, including people with lived experience of head and neck cancer, will take part in a single online or in-person focus group lasting approximately 1 to 1.5 hours to help co-design the digital malnutrition screening tool. In Phase 2, patients undergoing jaw reconstruction surgery for head and neck cancer will test the digital screening tool before surgery. Participants will complete a short survey (by phone or SMS), use the screening tool, and complete a final online survey. Participation is expected to take approximately 30 minutes in total. All participants will receive the study intervention relevant to their phase of participation. The study involves completion of surveys and testing of the digital malnutrition screening tool. No additional blood tests or cancer treatments are required as part of the study. It is hoped that this research will support the development and implementation of an effective patient-led screening approach to identify malnutrition earlier and improve nutritional care for people with head and neck cancer.

Interventions

The intervention is a digital, patient-led malnutrition screening tool for patients undergoing reconstruction surgeries for head and neck cancer (HNC) at Chris O’Brien Lifehouse (COBL). This study that will have 2 phases. Phase 1 will work with consumer advisory panel members from Chris O'Brien Lifehouse to co-design a digital patient-led malnutrition screening tool in partnership with IT specialists and healthcare professionals. This co-design workshop involves usability testing of the digita

The intervention is a digital, patient-led malnutrition screening tool for patients undergoing reconstruction surgeries for head and neck cancer (HNC) at Chris O’Brien Lifehouse (COBL). This study that will have 2 phases. Phase 1 will work with consumer advisory panel members from Chris O'Brien Lifehouse to co-design a digital patient-led malnutrition screening tool in partnership with IT specialists and healthcare professionals. This co-design workshop involves usability testing of the digital screening tool and a focus group to invite feedback on user experience. This phase will focus on the process of screening, including when it is introduced, how patients are asked to complete it and how these requests are worded. Feedback will be used by to refine and finalise the prototype before wider feasibility testing. Phase 2 will examine the feasibility of implementing the digital patient-led malnutrition screening tool (MST) pre-operatively for patients undergoing reconstruction surgeries for HNC. Usability will be assessed using the System Usability Scale (SUS), a validated 10-item questionnaire with Likert scale questions and corresponding scores based on responses. This survey will be conducted online. This questionnaire covers usability areas such as asking users to indicate how they found the system to use and if they needed to learn anything before using the system. Both phase 1 and 2 will be delivered by Shane McAuliffe, registered dietitian and PhD student. Phase 1 will be one online or in person focus group expected to be 1-1.5 hours total. Phase 2 will need to complete a short survey (over the phone or via SMS) followed by testing the tool and the a final online survey. This should all take about 30 minutes.

Sponsors

Chris O'Brien Lifehouse
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Primary purpose
Diagnosis

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Phase 1: Consumer advisory panel members at COBL will be eligible to participate in the study. Willingness to give informed consent and willingness to participate and comply with the study procedures will be required. We will aim to recruit panel members with lived experience of HNC specifically as part of the sample. Phase 2: All patients undergoing reconstruction surgery for HNC at COBL will be eligible for the study. Included participants must be >18 years, English-speaking and have access to a mobile device and internet to participate.

Exclusion criteria

Phase 1: Individuals unable/unwilling to provide informed consent for participation, non-English speaking, without access to a mobile device and internet will not be eligible to participate during this phase Phase 2: All patients <18 years, Individuals unable/unwilling to provide informed consent for participation, non-English speaking and without access to a mobile device and internet will not be eligible to participate during this phase

Outcome results

None listed

Source: ANZCTR · Data processed: Sep 19, 2026